David Reboussin to Psoriasis
This is a "connection" page, showing publications David Reboussin has written about Psoriasis.
Connection Strength
0.295
-
Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999 Sep; 41(3 Pt 1):401-7.
Score: 0.123
-
Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Bradham DD, Exum ML, Clark AR. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 1997 Oct; 37(4):564-9.
Score: 0.027
-
Fleischer AB, Clark AR, Rapp SR, Reboussin DM, Feldman SR. Commercial tanning bed treatment is an effective psoriasis treatment: results from an uncontrolled clinical trial. J Invest Dermatol. 1997 Aug; 109(2):170-4.
Score: 0.027
-
Fleischer AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR. Alternative therapies commonly used within a population of patients with psoriasis. Cutis. 1996 Sep; 58(3):216-20.
Score: 0.025
-
Fleischer AB, Feldman SR, Rapp SR, Reboussin DM, Exum ML, Clark AR, Rajashekhar V. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol. 1996 Jul; 107(1):26-9.
Score: 0.025
-
Feldman SR, Clark A, Reboussin DM, Fleischer AB. An assessment of potential problems of home phototherapy treatment of psoriasis. Cutis. 1996 Jul; 58(1):71-3.
Score: 0.025
-
Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996 Jan; 106(1):183-6.
Score: 0.024
-
Fleischer AB, Rapp SR, Reboussin DM, Vanarthos JC, Feldman SR. Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol. 1994 Jun; 102(6):967-9.
Score: 0.021